In a vital wake-up call for public health, researchers from the Indian Institute of Public Health have revealed that India’s medical research system systematically ignores the country's most vulnerable populations. Their recently published comprehensive review shows that millions of people living in urban slums, rural villages, and tribal areas are routinely excluded from clinical trials and health studies. Because these communities are not being actively studied, policymakers lack the vital information needed to protect them, creating a massive blind spot that has led to real-world consequences, such as unexpected disease outbreaks.
The researchers were exploring the social determinants of health research, a concept that examines how factors such as geography, gender, and social caste shape the focus of medical studies. When certain groups are excluded from research, studies fail to capture a complete picture of a nation's disease burden. The study highlights a tragic real-world consequence of this neglect by pointing to the 2022 measles outbreak in Mumbai’s Govandi slum. Because researchers had long overlooked the specific health needs and poor vaccine uptake in this densely populated, low-income area, the crisis went largely unnoticed until it was too late, resulting in hundreds of infections and several child deaths.
The research team adopted an integrative approach to data collection. Instead of relying solely on published research, which often fails to document the struggles of marginalised groups, they conducted a narrative review. This method allowed them to gather evidence from a wide variety of sources published between 2000 and 2025, including government policy documents, institutional reports, and investigative journalism. By including this grey literature, the researchers significantly improved upon previous studies that relied solely on academic databases. Those older, conventional reviews completely missed the systemic exclusions taking place on the ground, whereas this broader approach successfully captured the lived realities of ignored communities.
The findings expose a dual exclusion within the scientific system. Not only are vulnerable people left out of studies as participants, but scientists from these very communities face massive barriers to leading the research. Major funding and modern laboratories are heavily clustered in a few wealthy, urban metropolitan areas, leaving researchers in poorer rural states without adequate support. Furthermore, the study points out a glaring mismatch between what is actually making people sick and what gets researched. For instance, non-communicable diseases account for half of India's disease burden but receive less than a third of the research attention.
While the review provides a groundbreaking look into these structural disparities, the authors note a specific limitation in their methodology. Because the databases and archives were primarily indexed in English, the team only reviewed English-language sources, potentially missing valuable data published in India's many regional languages.
Nevertheless, the study highlights deep-seated flaws in the health research ecosystem and offers paths to correcting these. The authors suggest clear solutions, such as decentralising research funding, supporting scientists from marginalised castes, and creating a national framework to monitor fairness in health studies. By ensuring that medical research includes everyone, from individuals being studied to the scientists conducting them, health policies will become more accurate, trusted, and effective. When science truly reflects the diversity of the population it aims to serve, society is far better equipped to prevent future health crises and ensure fair medical treatment for all.
